Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Altimmune Inc (NQ: ALT )

11.78 USD -0.49 (-3.99%)
Official Closing Price Updated: 7:57 PM EDT, Apr 19, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 895,900
Open 12.10
Bid (Size) 11.70 (10)
Ask (Size) 11.98 (14)
Prev. Close 12.27
Today's Range 11.51 - 12.34
52wk Range 2.880 - 35.10
Shares Outstanding 37,150,376
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Alternus Energy Group (ALT) Completes 9 Million (91 Million NOK) Funding, Led by Nordic ESG and Impact Investor, AV Group Sarl
From NewMediaWire
Altimmune Reports Data from its Phase 1b Clinical Trial of NasoShield™
From GlobeNewswire News Releases

Performance

YTD
-7.32%
-7.32%
1 Month
-25.63%
-25.63%
3 Month
-13.32%
-13.32%
6 Month
-3.36%
-3.36%
1 Year
+264.71%
+264.71%

More News

Read More
Altimmune Partners with Summit Biosciences to Produce a Multidose Nasal Spray Presentation of its AdCOVID™ Vaccine Candidate
From GlobeNewswire News Releases
AdCOVID™, Altimmune’s Single Dose, Intranasal COVID-19 Vaccine Candidate, Prevents SARS-CoV-2-induced Disease and Blocks Viral Replication in Preclinical Studies of SARS-CoV-2 Infection
From GlobeNewswire News Releases
Altimmune Expands AdCOVID™ Manufacturing Collaboration with Lonza
From GlobeNewswire News Releases
DWAS's Underlying Holdings Imply 14% Gain Potential
Tags ETFs
From ETF Channel
Altimmune's Anthrax Vaccine Candidate Shows Early Safety, Immunogenicity In Healthy Volunteers
Tags Anthrax General Phase 1 Trial
From Benzinga
Could AstraZeneca's Nasal COVID Vaccine Development Zap Altimmune's Prospects?
Tags ALT AZN Market News
From Motley Fool
Altimmune's Shares Are Trading Higher On Intranasal COVID-19 Vaccine Candidate's Promising Action In Animal Studies
Tags Market News ALT Small Cap
From Benzinga
Thinking about buying stock in Invo Bioscience, Norwegian Cruise Line, Novan, Altimmune, or Transocean?
From PR Newswire
Why ContraFect, Evoke, Altimmune, Novavax Are Moving Friday
Tags CFRX Movers Biotech
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.